NextAR TKA Platform— 510(k) K202152

Substantially Equivalent

Medacta International S.A.

FDA 510(k) clearance K202152 for NextAR TKA Platform, Substantially Equivalent on 2020-10-27. Applicant: Medacta International S.A..

Clearance details

Applicant: Medacta International S.A.
Product code: Code SBF
Advisory panel: Neurology
Date received: 2020-08-03
Decision date: 2020-10-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Castel San Pietro (Ch), CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.